Repligen (FRA:RGN) Land And Improvements : €0.8 Mil (As of Mar. 2024)

View and export this data going back to . Start your Free Trial

What is Repligen Land And Improvements?

Repligen's land and improvements for the quarter that ended in Mar. 2024 was €0.8 Mil.

Repligen's quarterly land and improvements increased from Sep. 2023 (€0.9 Mil) to Dec. 2023 (€0.9 Mil) but then declined from Dec. 2023 (€0.9 Mil) to Mar. 2024 (€0.8 Mil).

Repligen's annual land and improvements increased from Dec. 2021 (€0.9 Mil) to Dec. 2022 (€0.9 Mil) but then declined from Dec. 2022 (€0.9 Mil) to Dec. 2023 (€0.9 Mil).

Repligen Land And Improvements Historical Data

The historical data trend for Repligen's Land And Improvements can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Repligen Land And Improvements Chart

Repligen Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Land And Improvements

Get a 7-Day Free Trial

0.92

0.84

0.91

0.95

0.91

Repligen Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Land And Improvements	Get a 7-Day Free Trial															0.94	0.90	0.89	0.91	0.79

Repligen Land And Improvements Calculation

Land is the surface or crust of the earth, which can be used to support structures, and may be used to grow crops, grass, shrubs, and trees. Land is characterized as having an unlimited life (indefinite). Land improvement is a long-term asset which indicates the cost of the constructed improvements to land, such as driveways, walkways, lighting, and parking lots.

Repligen (FRA:RGN) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Repligen Corp (FRA:RGN) » Definitions » Land And Improvements

Comparable Companies

Traded in Other Exchanges

RGEN:USA RGN:Germany

Address

41 Seyon Street, Building 1, Suite 100, Waltham, MA, USA, 02453

Website

https://www.repligen.com

Repligen Corp is a global life sciences company. It develops and commercializes innovative bioprocessing technologies and systems that increase efficiencies and flexibility in the process of manufacturing biological drugs. The company's customers include life science companies, global biopharmaceutical companies, and contract manufacturers worldwide. Repligen markets its products globally through a direct commercial organization in the U.S., Europe, and Asia, as well as through strategic partners in select markets. The majority of the company's revenue is generated in North America.

Repligen (FRA:RGN) Headlines

No Headlines